Smitha Antony
About
Smitha Antony is a scholar working on Molecular Biology, Toxicology and Immunology.
According to data from OpenAlex, Smitha Antony has authored 74 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 28 papers in Toxicology and 24 papers in Immunology. Recurrent topics in Smitha Antony's work include Cancer therapeutics and mechanisms (45 papers), Bioactive Compounds and Antitumor Agents (28 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (22 papers). Smitha Antony is often cited by papers focused on Cancer therapeutics and mechanisms (45 papers), Bioactive Compounds and Antitumor Agents (28 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (22 papers). Smitha Antony collaborates with scholars based in United States, Ukraine and United Kingdom. Smitha Antony's co-authors include Yves Pommier, Mark Cushman, Glenda Kohlhagen, James H. Doroshow, Yongzhong Wu, Jennifer L. Meitzler, Kurt W. Kohn, Olivier Sordet, Andrew Morrell and Richard L. Hayward and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The EMBO Journal.
In The Last Decade
Smitha Antony
72 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Smitha Antony United States | 40 | 2.9k | 1.2k | 1000 | 775 | 575 | 74 | 4.3k | ||
| Jack C. Yalowich United States | 38 | 2.9k 1.0× | 790 0.7× | 1.3k 1.3× | 411 0.5× | 203 0.4× | 114 | 4.5k | ||
| Atul Purohit United Kingdom | 41 | 2.4k 0.8× | 1.4k 1.2× | 549 0.5× | 439 0.6× | 192 0.3× | 102 | 4.7k | ||
| Marie Boyd United Kingdom | 25 | 2.0k 0.7× | 1.3k 1.1× | 722 0.7× | 336 0.4× | 186 0.3× | 73 | 4.6k | ||
| Jang‐Yang Chang Taiwan | 50 | 3.4k 1.2× | 1.6k 1.3× | 1.5k 1.5× | 288 0.4× | 311 0.5× | 201 | 6.6k | ||
| Michael C. Alley United States | 28 | 2.6k 0.9× | 1.3k 1.1× | 1.3k 1.3× | 307 0.4× | 246 0.4× | 48 | 5.2k | ||
| Sathees C. Raghavan India | 44 | 3.9k 1.4× | 1.1k 0.9× | 924 0.9× | 187 0.2× | 517 0.9× | 165 | 5.9k | ||
| Tsai‐Kun Li Taiwan | 39 | 3.5k 1.2× | 983 0.8× | 1.1k 1.1× | 640 0.8× | 171 0.3× | 82 | 5.3k | ||
| Caroline A. Austin United Kingdom | 40 | 4.5k 1.5× | 727 0.6× | 1.8k 1.8× | 664 0.9× | 169 0.3× | 135 | 5.4k | ||
| Jing‐Ping Liou Taiwan | 41 | 3.0k 1.0× | 2.3k 1.9× | 1.0k 1.0× | 229 0.3× | 200 0.3× | 182 | 5.4k | ||
| Matthias Ocker Germany | 39 | 2.9k 1.0× | 419 0.4× | 1.1k 1.1× | 374 0.5× | 342 0.6× | 161 | 5.0k |
Countries citing papers authored by Smitha Antony
Since
Specialization
Citations
This map shows the geographic impact of Smitha Antony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smitha Antony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smitha Antony more than expected).
Fields of papers citing papers by Smitha Antony
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Smitha Antony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smitha Antony. The network helps show where Smitha Antony may publish in the future.
Co-authorship network of co-authors of Smitha Antony
This figure shows the co-authorship network connecting the top 25 collaborators of Smitha Antony. A scholar is included among the top collaborators of Smitha Antony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smitha Antony. Smitha Antony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lu, Jiamo, Prabhakar Risbood, Larry Anderson, et al.. (2017). Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases. Biochemical Pharmacology. 143. 25–38.
2.
Meitzler, Jennifer L., Hala R. Makhlouf, Smitha Antony, et al.. (2017). Decoding NADPH oxidase 4 expression in human tumors. Redox Biology. 13. 182–195.
3.
Park, Sook Ryun, Robert J. Kinders, Sonny Khin, et al.. (2014). Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissues. Analytical Biochemistry. 459. 1–11.
4.
Meitzler, Jennifer L., Smitha Antony, Yongzhong Wu, et al.. (2013). NADPH Oxidases: A Perspective on Reactive Oxygen Species Production in Tumor Biology. Antioxidants and Redox Signaling. 20(17). 2873–2889.
5.
Doroshow, James H., Ágnes Juhász, Yun Ge, et al.. (2012). Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panel. Biochemical Pharmacology. 83(9). 1195–1207.
6.
Wu, Yongzhong, Smitha Antony, Ágnes Juhász, et al.. (2011). Up-regulation and Sustained Activation of Stat1 Are Essential for Interferon-γ (IFN-γ)-induced Dual Oxidase 2 (Duox2) and Dual Oxidase A2 (DuoxA2) Expression in Human Pancreatic Cancer Cell Lines. Journal of Biological Chemistry. 286(14). 12245–12256.
7.
Guirouilh‐Barbat, Josée, Smitha Antony, & Yves Pommier. (2009). Zalypsis (PM00104) is a potent inducer of γ-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition. Molecular Cancer Therapeutics. 8(7). 2007–2014.
8.
Stevens, Ellen V., Satoshi Nishizuka, Smitha Antony, et al.. (2008). Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Molecular Cancer Therapeutics. 7(1). 10–18.
9.
Dexheimer, Thomas S., Smitha Antony, Christophe Marchand, & Yves Pommier. (2008). Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 8(4). 381–389.
10.
Aune, Gregory J., Kazutaka Takagi, Olivier Sordet, et al.. (2008). Von Hippel-Lindau–Coupled and Transcription-Coupled Nucleotide Excision Repair–Dependent Degradation of RNA Polymerase II in Response to Trabectedin. Clinical Cancer Research. 14(20). 6449–6455.
11.
Pommier, Yves, Smitha Antony, Ze‐Hong Miao, et al.. (2007). Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Molecular Cancer Therapeutics. 6.
12.
Antony, Smitha, Keli Agama, Ze‐Hong Miao, et al.. (2007). Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance. Cancer Research. 67(21). 10397–10405.
13.
Antony, Smitha, et al.. (2007). Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Research. 35(13). 4474–4484.
14.
Marchand, Christophe, Krzysztof Krajewski, Hsiu-Fang Lee, et al.. (2006). Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Research. 34(18). 5157–5165.
15.
Xiao, Xiangshu, Smitha Antony, Yves Pommier, & Mark Cushman. (2006). Total Synthesis and Biological Evaluation of 22-Hydroxyacuminatine. Journal of Medicinal Chemistry. 49(4). 1408–1412.
16.
Antony, Smitha, Keli Agama, Ze‐Hong Miao, et al.. (2006). Bisindenoisoquinoline Bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA Intercalator and Topoisomerase Inhibitor with Antitumor Activity. Molecular Pharmacology. 70(3). 1109–1120.
17.
Xiao, Xiangshu, Ze-Hong Miao, Smitha Antony, Yves Pommier, & Mark Cushman. (2005). Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines. Bioorganic & Medicinal Chemistry Letters. 15(11). 2795–2798.
18.
Antony, Smitha. (2004). Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine. Nucleic Acids Research. 32(18). 5685–5692.
19.
Bates, Susan E., et al.. (2004). ABCG2 Mediates Differential Resistance to SN-38 (7-Ethyl-10-hydroxycamptothecin) and Homocamptothecins. Journal of Pharmacology and Experimental Therapeutics. 310(2). 836–842.
20.
Xiao, Xiangshu, Smitha Antony, Glenda Kohlhagen, Yves Pommier, & Mark Cushman. (2004). Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors. Bioorganic & Medicinal Chemistry. 12(19). 5147–5160.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jack C. Yalowich Breakdown of academic impact, for papers by Atul Purohit Breakdown of academic impact, for papers by Marie Boyd Breakdown of academic impact, for papers by Jang‐Yang Chang Breakdown of academic impact, for papers by Michael C. Alley Breakdown of academic impact, for papers by Sathees C. Raghavan Breakdown of academic impact, for papers by Tsai‐Kun Li Breakdown of academic impact, for papers by Caroline A. Austin Breakdown of academic impact, for papers by Jing‐Ping Liou Breakdown of academic impact, for papers by Matthias Ocker